DCF — MEMORIAL SATILLA HEALTH
Enterprise Value: $-108.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-108.9M
Enterprise Value
$-36.0M
PV of Cash Flows
$-72.9M
PV of Terminal Value
$-117.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $114.1M | $-5.9M | -5.0% | $-10.8M | $-9.8M |
| Year 2 | $117.5M | $-4.9M | -4.0% | $-9.9M | $-8.2M |
| Year 3 | $121.0M | $-3.9M | -3.0% | $-9.0M | $-6.8M |
| Year 4 | $124.7M | $-3.4M | -3.0% | $-8.7M | $-5.9M |
| Year 5 | $128.4M | $-3.2M | -2.0% | $-8.6M | $-5.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-108.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$110.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05708686604530802
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5